=== Page 176 ===
IBA Annual Report 2023 
173. 12.2. LIST OF EQUITY-ACCOUNTED INVESTMENTS 
NAME 
Country of incorporation 
Equity ownership (%) 
2023 
Equity ownership (%) 
2022 
Cyclhad SAS 
France 
33.33% 
33.33% 
Normandy Hadrontherapy SAS 
France 
39.81% 
39.81% 
Normandy Hadrontherapy SARL 
France 
50.00% 
50.00% 
Pantera NV/SA 
Belgium 
50.00% 
50.00% 
IBA does not account for its share of the loss in 
Cyclhad SAS and Normandy Hadrontherapy 
SAS above the value of its investment as there 
is no commitment to participate in any potential 
future capital increase.